Vatiquinone
PTC743-MIT-001-EP
Phase 3 small_molecule terminated
Quick answer
Vatiquinone for Mitochondrial Diseases is a Phase 3 program (small_molecule) at PTC THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PTC THERAPEUTICS, INC.
- Indication
- Mitochondrial Diseases
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated